We are live on ! Find out more
KA

Kozak & Associates Portfolio holdings

AUM $576M
1-Year Est. Return 23.37%
This Fund
S&P 500
This Quarter Est. Return
+12.15%
1 Year Est. Return
+23.37%
3 Year Est. Return
+97.43%
5 Year Est. Return
+117.62%
10 Year Est. Return
–
AUM
$248M
AUM Growth
+$25.2M
Cap. Flow
-$355K
Cap. Flow %
-0.14%
Top 10 Hldgs %
76.44%
Holding
367
New
28
Increased
133
Reduced
23
Closed
10

Top Buys

Rank Stock Value
1
IETC icon
iShares US Tech Independence Focused ETF
IETC
+$348K
2
XLV icon
State Street Health Care Select Sector SPDR ETF
XLV
+$337K
3
IYG icon
iShares US Financial Services ETF
IYG
+$239K
4
AAPL icon
Apple
AAPL
+$207K
5
DE icon
Deere & Co
DE
+$195K

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$605K
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$421K
3
IDXX icon
Idexx Laboratories
IDXX
+$400K
4
A icon
Agilent Technologies
A
+$319K
5
BIDU icon
Baidu
BIDU
+$178K

Sector Composition

Rank Sector Weight
1 Technology 15.19%
2 Consumer Discretionary 4.63%
3 Financials 4.62%
4 Consumer Staples 2.47%
5 Industrials 2.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PEP icon
101
PepsiCo
PEP
$190B
$106K 0.04%
573
+6
+1% +$1.12K
EFA icon
102
iShares MSCI EAFE ETF
EFA
$78B
$106K 0.04%
1,464
– –
RIO icon
103
Rio Tinto
RIO
$158B
$104K 0.04%
1,597
+54
+3% +$3.47K
SBUX icon
104
Starbucks
SBUX
$120B
$103K 0.04%
1,035
+3
+0.3% +$311
NOC icon
105
Northrop Grumman
NOC
$77.1B
$103K 0.04%
224
– –
LHX icon
106
L3Harris
LHX
$51.6B
$98.6K 0.04%
499
– –
ACN icon
107
Accenture
ACN
$102B
$98.6K 0.04%
317
– –
GEHC icon
108
GE HealthCare
GEHC
$30.7B
$96.6K 0.04%
1,197
– –
AZN icon
109
AstraZeneca
AZN
$263B
$95.3K 0.04%
730
– –
PAYC icon
110
Paycom
PAYC
$7.64B
$80K 0.03%
250
-485
-66% -$143K
IWO icon
111
iShares Russell 2000 Growth ETF
IWO
$14.3B
$78.9K 0.03%
325
– –
TROW icon
112
T. Rowe Price
TROW
$23.9B
$78.1K 0.03%
689
– –
AFL icon
113
Aflac
AFL
$64.9B
$78.1K 0.03%
1,112
– –
DUK icon
114
Duke Energy
DUK
$97.8B
$77.7K 0.03%
857
+10
+1% +$944
ETN icon
115
Eaton
ETN
$161B
$76K 0.03%
379
– –
LRCX icon
116
Lam Research
LRCX
$367B
$75.8K 0.03%
1,160
– –
BALL icon
117
Ball Corp
BALL
$17.3B
$71.3K 0.03%
1,218
– –
RY icon
118
Royal Bank of Canada
RY
$291B
$70.9K 0.03%
737
– –
NVO
119
Novo Nordisk
NVO
$208B
$70.6K 0.03%
886
– –
DAL icon
120
Delta Air Lines
DAL
$57.5B
$70.4K 0.03%
1,467
– –
TSCO icon
121
Tractor Supply
TSCO
$16.1B
$70.1K 0.03%
1,585
– –
MDT icon
122
Medtronic
MDT
$109B
$69.1K 0.03%
793
– –
MRSH
123
Marsh
MRSH
$90.5B
$66.2K 0.03%
357
+1
+0.3% +$177
TXN icon
124
Texas Instruments
TXN
$252B
$65.4K 0.03%
364
– –
MET icon
125
MetLife
MET
$61.9B
$63.8K 0.03%
1,113
– –
3 4
5
6 7

Similar funds

SCM
Simcoe Capital Management New York $576M AUM 36.22% 1-Year Est. Return
EIP
Ellis Investment Partners Berwyn, Pennsylvania $576M AUM 16.04% 1-Year Est. Return
GAM
Gould Asset Management Claremont, California $576M AUM 12.34% 1-Year Est. Return
MIOT
Massachusetts Institute of Technology Cambridge, Massachusetts $577M AUM 8.5% 1-Year Est. Return
PG
Patten Group Chattanooga, Tennessee $575M AUM 21.99% 1-Year Est. Return
WCCM
Webs Creek Capital Management Dallas, Texas $578M AUM 79.84% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
IDA
Intelligence Driven Advisers Carlsbad, California $574M AUM 16.47% 1-Year Est. Return

Kozak & Associates's Q2 2023 Portfolio in Review

As of Q2 2023, Kozak & Associates held 367 positions worth $248M, up 11% from $223M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Kozak & Associates's Q2 2023 filing shows 28 new, 133 increased, 23 reduced and 10 closed positions. Its largest new stake was iShares Core Universal USD Bond ETF: 536 shares worth $24.2K. The largest sale was Thermo Fisher Scientific, an estimated $605K.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Kozak & Associates's largest Q2 2023 buy was iShares Core Universal USD Bond ETF: 536 shares worth $24.2K.
  • Kozak & Associates added most to iShares US Tech Independence Focused ETF in Q2 2023, an estimated $348K increase.
  • Kozak & Associates's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $421K.
  • Kozak & Associates fully exited Thermo Fisher Scientific in Q2 2023, selling an estimated $605K.
  • Kozak & Associates's ten largest holdings make up 76% of its $248M portfolio in Q2 2023.
  • Kozak & Associates opened 28 new positions and closed 10 in Q2 2023.
  • Kozak & Associates's portfolio value rose 11% quarter-over-quarter to $248M.

Based on Kozak & Associates's 13F filing for Q2 2023, filed 5 Jul 2023.